SunBio, Inc. Logo

SunBio, Inc.

Biotechnology company specializing in PEGylation for therapeutic products.

067370 | KO

Overview

Corporate Details

ISIN(s):
KR7067370007
LEI:
Country:
South Korea
Address:
인천광역시 남동구 은봉로 129 -, 인천광역시

Description

SunBio, Inc. is a biotechnology company that develops biosimilars, biopharmaceuticals, and medical devices. The company's core activities are based on its proprietary PEGylation technology, a process that modifies molecules to enhance their therapeutic properties. SunBio's product portfolio includes PEG reagents for research and drug delivery, as well as biopharmaceutical candidates. Key development projects include MucoPEG™, a muco-adhesive hydrogel, and SBX, an artificial blood substitute. The company positions itself as a specialist in PEGylation, creating advanced therapeutic products for a global market.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2024-11-14 00:00
분기보고서 (2024.09)
Korean 1.0 MB
2024-09-05 00:00
증권발행결과(자율공시) (제4회차 CB)
Korean 5.6 KB
2024-09-03 00:00
주요사항보고서(전환사채권발행결정)
Korean 62.0 KB
2024-08-21 00:00
임시주주총회결과
Korean 6.6 KB
2024-08-14 00:00
반기보고서 (2024.06)
Korean 1008.6 KB
2024-08-06 00:00
주주총회소집공고
Korean 61.4 KB
2024-07-30 00:00
[기재정정]신규시설투자등
Korean 11.0 KB
2024-07-03 00:00
주주총회소집결의 (임시주주총회)
Korean 7.8 KB
2024-05-16 00:00
분기보고서 (2024.03)
Korean 971.5 KB
2024-04-17 00:00
[기재정정]신규시설투자등
Korean 11.0 KB
2024-03-29 00:00
정기주주총회결과
Korean 27.3 KB
2024-03-21 00:00
[기재정정]주주총회소집공고
Korean 102.9 KB
2024-03-21 00:00
사업보고서 (2023.12)
Korean 1.1 MB
2024-03-21 00:00
[기재정정]사업보고서 (2022.12)
Korean 1.1 MB
2024-03-14 00:00
주주총회소집공고
Korean 100.4 KB

Automate Your Workflow. Get a real-time feed of all SunBio, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for SunBio, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for SunBio, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.